| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 37.46▼ | 37.25▲ | 37.28▲ | 33.45▲ | 30.46▲ |
| MA10 | 37.31▲ | 37.21▲ | 36.76▲ | 31.34▲ | 32.40▲ |
| MA20 | 37.25▲ | 36.54▲ | 35.82▲ | 29.81▲ | 36.37▲ |
| MA50 | 37.16▲ | 34.48▲ | 31.97▲ | 32.83▲ | 31.23▲ |
| MA100 | 36.64▲ | 31.72▲ | 30.41▲ | 36.60▲ | 24.86▲ |
| MA200 | 35.83▲ | 30.27▲ | 30.02▲ | 32.26▲ | 26.15▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.031▲ | -0.074▼ | -0.018▼ | 1.224▲ | -0.911▼ |
| RSI | 64.285▲ | 69.880▲ | 82.665▲ | 71.361▲ | 57.231▲ |
| STOCH | 94.345▲ | 76.291 | 88.553▲ | 84.413▲ | 26.667 |
| WILL %R | -17.647▲ | -5.926▲ | -4.380▲ | -1.205▲ | -41.363 |
| CCI | 105.865▲ | 93.156 | 99.217 | 192.871▲ | 10.823 |
|
Monday, November 09, 2026 04:03 PM
Immunovant stock gains a new clinical focus after IMVT-1402 met its rheumatoid arthritis endpoint. FDA discussions are planned next. IMVT-1402 achieved the primary endpoint in the higher-dose ...
|
|
Monday, November 09, 2026 06:58 AM
Immunovant Inc (NASDAQ:IMVT) shares jumped 11.7% in early trading Monday after the company reported its drug candidate IMVT-1402 met the primary endpoint in a potentially registrational trial for ...
|
|
Sunday, November 08, 2026 11:00 PM
IMVT-1402 600 mg met the primary endpoint of ACR20 response at Week 28 (92.5% vs. 75.6% placebo, p=0.0139) in Period 2 (randomized withdrawal ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 35.80 | 37.58 | 35.63 | 37.46 | 1,207,729 |
| 10/11/26 | 35.15 | 35.98 | 34.83 | 35.71 | 1,643,134 |
| 09/11/26 | 33.32 | 35.61 | 32.81 | 35.15 | 3,979,193 |
| 06/11/26 | 28.73 | 30.61 | 28.34 | 30.53 | 2,658,239 |
| 05/11/26 | 29.78 | 29.83 | 28.12 | 28.39 | 1,119,632 |
| 04/11/26 | 29.82 | 29.93 | 28.495 | 29.90 | 1,270,484 |
| 03/11/26 | 28.70 | 29.48 | 28.42 | 29.04 | 1,079,583 |
| 02/11/26 | 29.32 | 29.64 | 28.38 | 28.41 | 1,268,029 |
| 30/10/26 | 29.49 | 29.78 | 28.755 | 29.17 | 1,165,416 |
| 29/10/26 | 29.56 | 30.15 | 29.33 | 29.64 | 1,399,285 |
|
|
||||
|
|
||||
|
|